(R)-2-(2-Fluorophenyl)pyrrolidine hydrochloride
95%
- Product Code: 87149
CAS:
1381929-34-5
| Molecular Weight: | 201.67 g./mol | Molecular Formula: | C₁₀H₁₃ClFN |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD08751399 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, sealed, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a fluorophenyl group and a pyrrolidine ring, makes it valuable for developing pharmaceuticals targeting the central nervous system. It is often employed in the creation of compounds with potential therapeutic effects on neurological disorders, such as depression, anxiety, and cognitive impairments. Additionally, its chiral nature allows for the exploration of enantioselective interactions in drug design, enhancing the specificity and efficacy of potential treatments. Researchers also use it in the study of receptor binding and enzyme inhibition, contributing to the development of novel drugs with improved safety profiles.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £502.37 |
+
-
|
(R)-2-(2-Fluorophenyl)pyrrolidine hydrochloride
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a fluorophenyl group and a pyrrolidine ring, makes it valuable for developing pharmaceuticals targeting the central nervous system. It is often employed in the creation of compounds with potential therapeutic effects on neurological disorders, such as depression, anxiety, and cognitive impairments. Additionally, its chiral nature allows for the exploration of enantioselective interactions in drug design, enhancing the specificity and efficacy of potential treatments. Researchers also use it in the study of receptor binding and enzyme inhibition, contributing to the development of novel drugs with improved safety profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :